KNC LABORATORIES CO., LTD.

Highlights KNC Laboratories Co., Ltd.

Equities

6568

JP3290400005

Delayed Japan Exchange Other stock markets 05:20:43 14/06/2024 BST			5-day change	1st Jan Change
1,296 ^JPY	-0.84%		+0.86%	-10.81%

03-14	KNC Laboratories Co., Ltd. acquired an unknown stake in NapaJen Pharma, Inc. from INCJ, Ltd.	CI
2022	Tranche Update on KNC Laboratories Co., Ltd.'s Equity Buyback Plan announced on May 13, 2022.	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

KNC Laboratories Co., Ltd. acquired an unknown stake in NapaJen Pharma, Inc. from INCJ, Ltd.	03-13	CI
Tranche Update on KNC Laboratories Co., Ltd.'s Equity Buyback Plan announced on May 13, 2022.	16/05/22	CI
KNC Laboratories Co., Ltd.'s Equity Buyback announced on May 13, 2022, has closed with 100,000 shares, representing 1.29% for ¥111.5 million.	15/05/22	CI
KNC Laboratories Co., Ltd. announces an Equity Buyback for 100,000 shares, representing 1.29% for ¥111.5 million.	13/05/22	CI
KNC Laboratories Co., Ltd. authorizes a Buyback Plan.	12/05/22	CI
KNC Laboratories Co., Ltd. has completed an IPO in the amount of ¥5.30712 billion.	14/03/18	CI
KNC Laboratories Co., Ltd. has filed an IPO.	09/02/18	CI
Kobe University, Knc Laboratories Co.,Ltd., and Dainippon Sumitomo Pharma Co., Ltd. Signs License Agreement and Joint Research Agreement	26/12/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW